Literature DB >> 977330

Propranolol for migraine prophylaxis.

B Forssman, K G Henriksson, V Johannsson, L Lindvall, H Lundin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 977330     DOI： 10.1111/j.1526-4610.1976.hed1605238.x

Source DB:  PubMed          Journal:  Headache        ISSN： 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  12 in total

1.  The pharmacological management of migraine, part 2: preventative therapy.

Authors:  George Demaagd
Journal:  P T       Date:  2008-08

2.  Beta-blockers in migraine prophylaxis.

Authors:  M Anthony
Journal:  Drugs       Date:  1978-04       Impact factor: 9.546

Review 3.  Current and investigational drugs for the prevention of migraine in adults and children.

Authors:  Frederick G Freitag; Derrick Shumate
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749

4.  Headache.

Authors:  R Atkinson; O Appenzeller
Journal:  Postgrad Med J       Date:  1984-12       Impact factor: 2.401

5.  Propranolol for acute migraine.

Authors:  R Tokola; E Hokkanen
Journal:  Br Med J       Date:  1978-10-14

Review 6.  Practical approaches to migraine management.

Authors:  Seymour Diamond; Richard Wenzel
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

7.  Preventive pharmacologic treatments for episodic migraine in adults.

Authors:  Tatyana A Shamliyan; Jae-Young Choi; Rema Ramakrishnan; Jennifer Biggs Miller; Shi-Yi Wang; Frederick R Taylor; Robert L Kane
Journal:  J Gen Intern Med       Date:  2013-04-17       Impact factor: 5.128

8.  [Drug treatment as migraine prophylaxis.].

Authors:  H C Diener; A Ziegler
Journal:  Schmerz       Date:  1989-12       Impact factor: 1.107

9.  A prospective, open-label study of milnacipran in the prevention of headache in patients with episodic or chronic migraine.

Authors:  Emily Rubenstein Engel; David Kudrow; Alan M Rapoport
Journal:  Neurol Sci       Date:  2013-09-13       Impact factor: 3.307

Review 10.  Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine.

Authors:  K E Andersson; E Vinge
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.